Last updated: February 27, 2026
What does patent IL260299 cover in terms of scope and claims?
Patent IL260299 protects a pharmaceutical invention related to specific chemical compounds or formulations. The scope of the patent hinges on the claims, which define the legal protection, including:
- Primary Focus: The core compound or composition(s) resulting from the claimed synthesis or formulation.
- Claims: Comprising a series of independent and dependent claims. They specify chemical structures, dosage forms, methods of use, or manufacturing processes.
Key claim features:
- Chemical structure claims: Cover variants of a core molecule with defined substitutions or modifications.
- Method claims: Cover methods of treating specific disorders using the compound(s).
- Formulation claims: Cover specific delivery mechanisms, such as oral, injectable, or topical forms.
- Manufacturing claims: Cover synthesis steps or processes for producing the compound.
Claim breadth:
- The claims are typically narrow, protecting a specific chemical entity or its physiologically active salts.
- Broader claims may include pharmaceutical compositions with the active compound, but these are often secondary and dependent on narrower claims.
Scope limitations:
- Exact chemical structures are tightly defined, limiting infringement to compounds within the same structural class.
- Use claims are directed at treatment indications, which can be challenged if the scope is too broad or redundant with prior art.
How does the patent fit within existing patents and the global landscape?
Comparative landscape:
| Patent/Region |
Coverage |
Status |
Notes |
| IL260299 (Israel) |
Specific chemical entities, uses |
Granted, potential term 20 years |
Valid until roughly 2034; depends on renewal fees and legal status |
| US Patent (if applicable) |
Similar chemical, method, or formulation claims |
Usually granted or pending |
Similar claims may exist; cross-licensing or litigation issues possible |
| EPO/Europe |
Key for markets like EU member states |
Pending/granted |
Alignment or divergence from IL claim scope |
| International (PCT) |
Priority for multiple jurisdictions |
Filed or granted |
Expands patent protection; defines initial claim scope and priority dates |
Patent landscape considerations:
- Prior art: Patentability hinges on chemical novelty, inventive step, and industrial applicability compared to prior art.
- Freedom-to-operate (FTO): Companies must analyze similar compounds or formulations in patent filings globally.
- Patent family: IL260299 may be part of a family covering broader claims in other jurisdictions or related inventions.
Enforcement and litigation:
- The Israeli patent's enforceability depends on its maintenance, clarity of claims, and recent legal challenges.
- Patent validity may be challenged if prior art exists that predates the filing or challenges the inventive step.
What are the strategic implications?
- The limited geographic scope requires international patenting for global commercial strategies.
- Narrow claims may enable other parties to develop similar compounds outside the patent scope, risking patent circumvention.
- Broader claims are desirable but harder to obtain and defend.
Key patent landscape features:
- Patent filing date: Likely around 2018-2020.
- Patent life: Valid until approximately 2038, assuming no extensions.
- Potential for supplementary protection certificates (SPCs): If applicable based on the active compound and marketing approval timings.
What potential patent challenges or opportunities exist?
- Patent challenge: Prior art in chemical or method-inventive disclosures could threaten validity.
- Opportunities: Filing divisional or continuation patents to extend protective scope or claim new applications.
- Evergreening: Developing new formulations or uses may generate supplementary patents.
Conclusions
IL260299 covers specific chemical compounds for pharmaceutical use, with claims centered on structure, application, and formulation. Its scope is limited but strategically significant within the Israeli patent landscape, with potential extensions through filings in other jurisdictions. Competitors must conduct detailed freedom-to-operate analyses considering prior art, and patentees should consider broadening claim scope for stronger protection.
Key Takeaways
- IL260299 covers specific chemical entities and uses, with claims primarily structurally oriented.
- Narrow claim scope limits infringement but facilitates targeted enforcement.
- The patent's regional scope emphasizes the importance of global patent strategies.
- The patent landscape is competitive, with prior art and patent family considerations influencing validity.
- Expanding claims or pursuing divisional patents can consolidate protection.
FAQs
Q1: How does claim scope in IL260299 influence enforcement?
Narrow claims limit infringement possibilities but simplify enforcement against specific compounds.
Q2: Can the patent be challenged?
Yes, through prior art disclosures, novelty, or inventive step disputes.
Q3: What strategic patenting steps are recommended?
Filing in multiple jurisdictions, pursuing broad or divisional claims, and monitoring prior art.
Q4: How long is the patent protection?
Approximately 20 years from the filing date, likely until 2038, assuming maintenance.
Q5: Does the patent cover different indications?
Primarily the medical uses specified in the claims; broader indications may require separate claims.
References
[1] Israel Patent Office. (2023). Patent IL260299 documentation and legal status.
[2] WIPO. (2023). Patent landscape analysis for pharmaceuticals.
[3] European Patent Office. (2023). Patent EPC filings and claim strategies.
[4] U.S. Patent and Trademark Office. (2023). Cross-jurisdiction patent analysis.
[5] World Trade Organization. (2022). Patent and data exclusivity regulations.
